IMPAIRMENT OF METHIONINE METABOLISM IN LIVER-DISEASE

被引：14

作者：

CORRALES, F ^{[1
]}

ALVAREZ, L ^{[1
]}

PAJARES, MA ^{[1
]}

ORTIZ, P ^{[1
]}

MATO, JM ^{[1
]}

机构：

[1] CSIC,INST INVEST BIOMED,ARTURO DUPERIER 4,E-28029 MADRID,SPAIN

来源：

DRUG INVESTIGATION | 1992年 / 4卷

关键词：

D O I：

10.1007/BF03258359

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Methionine metabolism is impaired in patients with liver damage and this alteration might complicate and maintain the clinical syndrome. Alterations in this pathway are associated with a defect in S-adenosyl-L-methionine (SAMe) synthetase activity. Liver glutathione, which is derived from SAMe via the transsulphuration pathway, is also depleted as a result of liver damage. Glutathione appears to protect against SAMe synthetase inactivation by preventing oxidation of sulfhydryl groups; thus, its depletion further reduces SAMe synthetase activity, and a vicious circle may develop. Restoration of glutathione levels by the addition of treatment with SAMe or glutathione esters in various experimental conditions (buthionine sulfoximine and carbon tetrachloride intoxication) has resulted in attenuation of the damage produced by the toxins. Moreover, exogenously administered SAMe has been used successfully in patients with liver disease. The elucidation of the mechanisms that regulate methionine metabolism might lead to the development of new therapeutic approaches in liver disease.

引用

页码：8 / 13

页数：6

共 40 条

[1]

Abe T., Okada G., Teraoka H., Tsukada K., Immunological distinction of S-adenosylmethionine synthetase isoenzymes from rat liver and kidney, Journal of Biochemistry (Tokyo), 91, pp. 1081-1084, (1982)

[2]

Alvarez L., Asuncion M., Corrales F., Pajares M.A., Mato J.M., Analysis of the 5′ non-coding region of rat liver S-adenosylmethionine synthetase mRNA and comparison of the M<sub>r</sub> deduced from the cDNA sequence and the purified enzyme, FEBS Letters, 290, pp. 142-146, (1991)

[3]

Anderson M.E., Powrie F., Puri R.N., Meister A., Glutathione monoethyl ester: preparation, uptake by tissues, and conversion to glutathione, Archives in Biochemistry and Biophysics, 239, pp. 538-548, (1985)

[4]

Bray G.P., Tredger J.M., Willia R., S-Adenosylmethionine protection against acetaminophen hepatotoxicity in two mouse models, Hepatology, 15, pp. 297-301, (1992)

[5]

Burgunder J.M., Varriale A., Lauterburg B.H., Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration, European Journal of Clinical Pharmacology, 36, pp. 127-131, (1989)

[6]

Cabrero C., Alemany S., Conversion of rat liver S-adenosyl-L-me-thionine synthetase from high-Mr to low-Mr form by LiBr, Biochimica et Biophysica Acta, 952, pp. 277-281, (1988)

[7]

Cabrero C., Martin-Duce A., Ortiz P., Alemany S., Mato J.M., Specific loss of the high-molecular weight form of S-adenosyl-L-methionine synthetase in human liver cirrhosis, Hepatology, 8, pp. 1530-1534, (1988)

[8]

Cabrero C., Puerta J., Alemany S., Purification and comparison of two forms of S-adenosyl-L-methionine synthetase from rat liver, European Journal of Biochemistry, 170, pp. 299-304, (1987)

[9]

Cantoni G.L., S-Adenosylmethionine revisited, Transmethylation and methionine biosynthesis, pp. 21-32, (1965)

[10]

Cantoni G.L., Biochemical methylations: selected aspects, Annual Review of Biochemistry, 44, pp. 435-451, (1975)

← 1 2 3 4 →